Yunnan Baiyao Group Co.,Ltd (000538.SZ)

56.71 +0.71 (+1.27%) At close: 03:05PM CST

Yunnan Baiyao Group Co.,Ltd

No. 3686, Yunnan Baiyao Street
Chenggong District
Kunming 650500
China
86 871 6632 4159
https://www.yunnanbaiyao.com.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 8,834

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ming Dong	CEO, President & Director	N/A	N/A	1976
Mr. Pin Yao Yin	COO, Senior VP & President of Chinese Medicine Resources Division	N/A	N/A	1969
Mr. Yong Yang	Chief Compliance Officer & Senior VP	N/A	N/A	1964
Ms. Juan Yu	Chief Human Resources Officer	N/A	N/A	1972
Mr. Jing Li	Chief Quality & Process Officer	N/A	N/A	1965
Ms. Jin Wang	Chief Sales Officer, Senior VP & President of Pharmaceutical Division	N/A	N/A	1970
Mr. Wanmin Qin	Chief Innovation Officer, Senior VP & President of Health Products Division	N/A	N/A	1964
Mr. Jia Ma	Chief Financial Officer	N/A	N/A	1977
Mr. Zhang Ning	Chief Scientist	N/A	N/A	1971

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, and Chinese medicine resources. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Corporate governance

Yunnan Baiyao Group Co.,Ltd’s ISS governance QualityScore as of 1 April 2024 is 8. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 2; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.